[Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy].
PubMed
December 20, 1988
Cited by 0
Related Papers
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group
|Archivio Italiano di Urologia e Andrologia|2015|202
Prevalence, Incidence Estimation, Risk Factors and Characterization of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Urological Hospital Outpatients in Italy: Results of a Multicenter Case-Control Observational Study
|The Journal of Urology|2007|181
Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas
|International Journal of Cancer|1999|97
Italian validation of the International Consultation on Incontinence Questionnaires
|British Journal of Urology|2005|84